Stefano Savonitto

TL;DR: Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock, the 30‐day risk of a composite of death or severe renal failure leading to renal‐replacement therapy was lower among those who initially underwent PCI of the culprit lesion only than amongThose who underwent immediate multivessels PCI.

TL;DR: Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrine therapy and platelet glycoprotein IIb/IIIa inhibition : the GUSTO V randomised trial.

TL;DR: Neither facilitation of PCI with reteplase plus abcximab nor facilitation with abciximab alone significantly improved the clinical outcomes, as compared with ab ciximabs given at the time of PCI, in patients with ST-segment elevation myocardial infarction.

TL;DR: The ECG category and creatine kinase level at admission remained highly predictive of death and myocardial infarction after multivariate adjustment for the significant baseline predictors of events.

TL;DR: Immediate transfer for PCI improves outcome in high-risk patients with STEMI treated at a non-interventional centre with half-dose reteplase and abciximab in case of persistent ST-segment elevation or clinical deterioration.